{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:35:04Z","timestamp":1758638104159,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ihj.2017.05.026","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T01:47:43Z","timestamp":1496195263000},"page":"453-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["High versus low dose statin therapy in Indian patients with acute ST-segment elevation myocardial infarction undergoing thrombolysis"],"prefix":"10.1016","volume":"69","author":[{"given":"K.","family":"Priti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanwar L.","family":"Ranwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.ihj.2017.05.026_bib0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.CIR.97.6.596","article-title":"Emerging epidemic of cardiovascular disease in developing countries","volume":"97","author":"Reddy","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.05.026_bib0010","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.90.2.1056","article-title":"Coronary artery disease regression: convincing evidence for the benefit of aggressive lipoprotein management","volume":"90","author":"Superko","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.05.026_bib0015","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ihj.2017.05.026_bib0020","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDeAL Study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2017.05.026_bib0025","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ihj.2017.05.026_bib0030","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.05.026_bib0035","first-page":"e82","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.05.026_bib0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcin.2009.11.021","article-title":"Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial","volume":"3","author":"Kim","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2017.05.026_bib0045","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"On behalf of MIRACL Study Investigators: effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL Study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2017.05.026_bib0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: west of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2017.05.026_bib0055","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2017.05.026_bib0060","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.amjcard.2007.01.028","article-title":"Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial)","volume":"99","author":"Deedwania","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2017.05.026_bib0065","first-page":"97","article-title":"Post-marketing study of clinical experience of atorvastatin 80\u2009mg vs. 40\u2009mg in Indian patients with acute coronary syndrome \u2013 a randomized, multi-centre study (CURE-ACS)","volume":"61","author":"Kaul","year":"2013","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.ihj.2017.05.026_bib0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clpt.2005.06.013","article-title":"Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment","volume":"78","author":"Lee","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ihj.2017.05.026_bib0075","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/01.RES.0000099503.13312.7B","article-title":"Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibi-tion on coronary endothelial function","volume":"93","author":"Wassmann","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.ihj.2017.05.026_bib0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.amjcard.2005.02.050","article-title":"Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography","volume":"96","author":"Hinoi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2017.05.026_bib0085","doi-asserted-by":"crossref","first-page":"54F","DOI":"10.1016\/j.amjcard.2005.06.027","article-title":"Early time to benefit with intensive statin treatment: could it be the pleiotropic effects","volume":"96","author":"Ray","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2017.05.026_bib0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/clpt.2010.255","article-title":"Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study","volume":"89","author":"Donnelly","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ihj.2017.05.026_bib0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0971-6866.142896","article-title":"Prevalence of genetic variants associated with cardiovascular disease risk and drug response in the Southern Indian population of Kerala","volume":"20","author":"Mahadevan","year":"2014","journal-title":"Indian J Hum Genet"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483216310239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483216310239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:48:46Z","timestamp":1758080926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483216310239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0019483216310239"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2017.05.026","relation":{},"ISSN":["0019-4832"],"issn-type":[{"type":"print","value":"0019-4832"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High versus low dose statin therapy in Indian patients with acute ST-segment elevation myocardial infarction undergoing thrombolysis","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2017.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}